Atlas Trials

Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT

Clinical trial NCT02980653 · UNKNOWN

Trial details

NCT number
NCT02980653
Sponsor
TTY Biopharm
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2015-05-01
Primary completion
2017-08-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.